Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmaceutical drug class
|
| gptkbp:contraindication |
hypersensitivity to drug
|
| gptkbp:discoveredIn |
1970s
|
| gptkbp:example |
gptkb:octreotide
gptkb:lanreotide gptkb:pasireotide |
| https://www.w3.org/2000/01/rdf-schema#label |
somatostatin analogs
|
| gptkbp:inhibitedBy |
insulin secretion
glucagon secretion growth hormone secretion |
| gptkbp:mechanismOfAction |
somatostatin receptor agonist
|
| gptkbp:relatedTo |
gptkb:somatostatin
|
| gptkbp:routeOfAdministration |
intramuscular injection
subcutaneous injection |
| gptkbp:sideEffect |
bradycardia
gastrointestinal upset hyperglycemia gallstones |
| gptkbp:usedFor |
gptkb:carcinoid_syndrome
acromegaly neuroendocrine tumors |
| gptkbp:bfsParent |
gptkb:VIPomas
gptkb:carcinoid_tumors gptkb:pancreatic_neuroendocrine_tumors |
| gptkbp:bfsLayer |
6
|